Journal of Leukemia
Open Access

Pediatric Oncology Department, National Cancer Institute, Cairo University, Children Cancer Hospital 57357, Egypt

Biography

Youssef Madney is a Pediatric Oncology Consultant. He has done his MD in  Pediatric Oncology from National Cancer Institute, Cairo University, and MSc. of Pediatrics from Faculty of Medicine, Cairo University, and BSc. in Medicine and Surgery from Faculty of Medicine, Cairo University.

Publications

• Research Article   
  Role of Minimal Residual Disease in the Clinical Course of T cell Acute Lymphoblastic Leukemia in Pediatric Patients
  Author(s): Eman Kandeel, Youssef Madney*, Randa Amin and Azza Kamel
  
  Background Minimal Residual Disease (MRD) is the most important prognostic parameter in pediatric precursor B cell- Acute Lymphoblastic Leukemia (B-ALL). However, the feasibility of flow cytometry in the detection of Minimal Residual Disease (MRD) in T cell- Acute Lymphoblastic Leukemia (T-ALL) is not well defined. Objectives We aimed to investigate the prognostic impact of Flow Cytometry-MRD in T-ALL measured at different time points post-induction. Patients and methods In the current study, the impact of MRD was investigated in 58 newly diagnosed pediatric ALL at day 15, 28 and 42 post induction treatment in relation to other clinical and hematological parameters as well as disease-free survival. Results At day 15, day 28 and day 42 patients with .. View More»
  DOI: 10.35248/2329-6917.19.7.256

  Abstract HTML PDF